Share This

Public company info - Luye Pharma Group Ltd. , 02186.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Luye Pharma Group Ltd., 02186.HK - Cash Flow 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12
Net Cash Flow from Operating Activities 2,108,501 1,382,156 1,211,419 753,301 519,767 462,801 543,989 257,963
Net Cash Flow from Return on Investments & Servicing of Finance -473,499 -354,201 -245,057 -61,115 -9,539 -25,835 -35,510 -30,362
　Interest Received 90,012 58,048 24,303 78,821 9,000 22,099 3,030 3,858
　Interest Paid -187,013 -157,717 -51,801 -29,085 -13,971 -40,321 -26,360 -34,220
　Dividend Received 911 40,389 352 693 0 0 0 0
　Dividend Paid -377,409 -294,921 -217,911 -111,544 -4,568 -7,613 -12,180 0
　Others 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -176,591 -178,852 -195,516 -132,188 -111,088 -103,384 -78,003 -70,841
Net Cash Flow from Investing Activities -2,782,463 -3,096,185 -768,351 -1,914,409 231,318 -3,000,886 -557,406 -138,988
　Additions to Fixed Assets -970,387 -728,165 -507,322 -263,411 -204,107 -268,836 -265,016 -146,240
　Disposal of Fixed Assets 256 2,725 834 110 971 25,162 642 1,677
　Increase in Investments -3,379,477 -3,598,681 -4,611,400 -6,228,489 -5,138,720 -1,840,465 -10,000 -3,000
　Decrease in Investments 3,462,740 3,325,000 4,466,668 4,511,806 5,655,080 25,892 0 0
　Net Cash Flow with Related Parties 2,864 0 0 0 0 0 0 0
　Others -1,898,459 -2,097,064 -117,131 65,575 -81,906 -942,639 -283,032 8,575
Net Cash Flow before Financing Activities -1,324,052 -2,247,082 2,495 -1,354,411 630,458 -2,667,304 -126,930 17,772
Net Cash Flow from Financing Activities 1,984,165 2,699,567 950,488 931,557 55,878 2,665,425 99,500 91,517
　New Loans 6,805,064 9,219,870 3,866,794 3,404,215 1,491,471 1,747,242 1,298,436 824,338
　Loans Repayment -6,756,017 -5,943,084 -2,629,550 -2,282,817 -1,294,293 -2,187,013 -1,023,915 -809,366
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0
　Equity Financing 2,041,127 0 0 0 0 3,054,926 0 0
　Net Cash Flow with Related Parties 2,864 0 0 0 0 0 0 0
　Others -108,873 -577,219 -286,756 -189,841 -141,300 50,270 -175,021 76,545
Increase(Decrease) in Cash & Cash Equivalents 660,113 452,485 952,983 -422,854 686,336 -1,879 -27,430 109,289
Cash & Cash Equivalents at Beginning of Year 1,672,865 1,265,872 -84,886 843,674 151,863 333,150 364,031 251,501
Net Cash Flow due to Change in Exchange Rate/Others -7,532 -45,492 397,775 -23,045 5,475 592 -3,451 3,241
Cash & Cash Equivalents at End of Year 2,325,446 1,672,865 1,265,872 397,775 843,674 331,863 333,150 364,031
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.